Summary: Human (HepG2) and rat (MH1C1) hepatoblastoma cells were incubated with different concentrations of the hypolipidaemics cetaben, clofibrate and thyroxine. The enzymatic activities of catalase, peroxisomal bifunctional enzyme, succinate dehydrogenase, and 3-oxoacyl-CoA thiolase were measured. In order to determine the point of regulation of the enzymatic activities Northern and Slot blot experiments with probes for peroxisomal bifunctional enzyme, catalase and fatty acyl CoA oxidase were performed on total RNA. Catalase activity was enhanced in HepG2 cells treated with 3 rrimol/1 clofibric acid to 135% of control and the mRNA value to 2.6 fold, whereas in cetaben treated cells the enhancement (up to 119% of control) was less pronounced. In MH1C1 cells catalase activity was not changed by any of the drugs. The activity of the peroxisomal bifunctional enzyme was not affected in HepG2 cells by clofibric acid and cetaben, whereas the mRNA level was elevated to 2.3 fold by 10 μτηοΐ/l cetaben. At high concentrations of cetaben all enzyme activities were decreased in both cell lines due to its high cytotoxicity. Our data show that, due to the differences in the genomic organisation, the regulation of the enzyme activities is different in human and rat, but the results from the human and rat hepatoblastoma cells correlate with the findings in whole man and rat, so that a human in vitro system is more suitable for pharmacological tests. These results suggest that the human hepatoma cell line HepG2 may be a useful model system for studies of the influence of hypolipidaemics on the peroxisomal enzyme system.
Introduction
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A different class of chemicals, lowering the concentration of lipids in blood and also noted for peroxisome proliferative efficiency, is represented by several alkylaminobenzoic acids (7) . Chandoga et al. (8) have reported on the effect of cetaben (sodium /?-hexadecyl aminobenzoate), a representative of this class of non fibrate peroxisome proliferators, on the activities of peroxisomal enzymes in liver and kidney of rats, but little is known about their effects in humans.
Like clofibrate, thyroid hormones lead to proliferation of liver peroxisomes (9) . Furthermore, thyroid hormones increase the peroxisomal fatty acid ß-oxidation, presumably by inducing acyl-CoA oxidase (10), the rate limiting enzyme of this pathway (11) . Various models describe the modulation of thyroid hormone action by differential mechanisms via homo-or heterodimerization with nuclear receptors (12) .
The regulation of the induction of peroxisomal enzymes seems to be different in different species (4, 13) . In rat a single acyl-CoA oxidase gene is present, which gives rise to two different mRNAs by differential splicing (14) . Schepers et al. (15) identified two different fatty acyl-CoA oxidases in rat liver, one of which is inducible by clofibrate. Only one gene for enoyl-CoA hydratase : 3-hydroxyacyl-CoA dehydrogenase has been identified in rat (16) , which is inducible. Finally, two genes for peroxisomal 3-oxoacyl-CoA thiolase are present in rat; one is inducible by clofibrate (17) . Thus, entirely different mechanisms are responsible for the induction of individual peroxisomal ß-oxidation enzymes in rodents by clofibrate, e. g. The situation in human appears to be different, as there is only a single gene for peroxisomal 3-oxoacyl-CoA thiolase (18) , and also only one for fatty acyl-CoA oxidase, with properties similar to those of the non-inducible isoform in rat liver (19) . This may be related to the fact that compounds like clofibrate do not induce peroxisomal ß-oxidation enzymes in primates (20) . In this respect it will be of interest to see if the response in primates correlates with the response in human.
The aim of the present study was to show the difference in the regulation of induction of peroxisomal enzymes by peroxisomal proliferators in comparison of rats and human. A rat and a human hepatonaa cell line, MH1C1 and HepG2, respectively, were selected as model systems. In our approach we were able to demonstrate the differential regulation of the induction of peroxisomal enzymes as a response to the application of hypolipidaemic drugs on cell cultures of human and rat liver cells.
Materials and Methods
Cell culture Triiodothyronine (50 mmol/1 stock solution) was prepared in 0.01 mol/1 NaOH. Incubation media were sonicated for 10 min at room temperature before use. Treatment of the confluent monolayers was commenced by replacing the culture media with incubation media supplemented with the test compounds. Incubations were carried out for 24 hours. The monolayers were washed two times with phosphate buffered saline. The cells were detached by means of trypsin-EDTA (0.5 g/1 trypsin, 0.2 g/1 EDTA) for 5 min at 37 °C. Cell suspensions were sedimented for 5 min at 300 g, resuspended, centrifuged again and suspended in ice cold phosphate buffered saline.
Enzyme assays
For the determination of catalase activity, cells were incubated with 10 g/1 Triton X-100 for 2 min prior to the assay. Poly (A+) RNA was isolated using the PolyATtract mRNA isolation system III of Promega according to the manufacturer's instructions (Promega; Madison, USA).
Northern-and slot-blot analysis RNA was separated by electrophoresis on 1% agarose gels under denaturing conditions and then transferred to Hybond-N membranes (Amersham; Little Chalfont, UK) by capillary blotting technique (26) . RNA molecular weight marker II (Boehringer Mannheim; Mannheim, Germany) was used as size standard in RNA gel electrophoresis.
For slot-blot analysis total RNA was denatured with formaldehyde and applied to Hybond-N membranes. RNA was fixed to the membranes by UV-crosslinking. The probes used in the hybridisation procedures included restriction fragments of Pstl fragment of rat acyl CoA oxidase (686 bases) (27) , cDNA probes were labelled with [a-32 P]dCTP using the NEBlot Kit (New England Biolabs; Beverly, USA) (32) . Membranes were prehybridised in a solution containing 500 g/1 formamide, 0.75 mol/1 NaCl, 75 mmol/1 sodium citrate (pH = 7), 0.4 g/1 Ficoll 400, 0.4 g/1 polyvinylpyrrolidone, 0.4 g/1 bovine serum albumin (Fraction V), 1 g/1 SDS, 200 mg/1 salmon sperm DNA and 100 g/1 dextran sulphate at 42 °C for 2 h and after addition of the denatured probes hybridisation was carried out overnight. Membranes were washed twice for 15 min in 0.3 mol/1 NaCl, 30 mmol/1 sodium citrate (pH = 7), 1 g/1 SDS, at room temperature, followed by two washes for 15 min at 42 °C in 0.15 mol/1 NaCl, 15 mmol/1 sodium citrate (pH =7), 1 g/1 SDS. Membranes were autoradiographed using Kodak X-Omat films and intensifying screens (Kodak; Rochester, USA).
After autoradiography, the RNA filters were washed using 0.005 moVl Tris-HCl (pH 8.0), 0.002 mol/1 EDTA and 0.02 g/1 Ficoll 400, 0.02 g/1 polyvinylpyrrolidone, 0.02 g/1 bovine serum albumin (Fraction V), 0.05 g/1 SDS for 2 h at 65 °C and reprobed. Membranes treated this way revealed no signs of diminished quality after reprobing. Human and mouse -actin cDNA were used to rehybridise the membranes and served as an internal standard for the normalisation of the RNA levels. Slot blots were quantified by counting each blot with the Instantlmager {Canberra Packard; Meriden, USA), and densitometry was performed using the Pharmacia Image Master (Pharmacia; Uppsala, Sweden).
Cytotoxicity assay
Cytotoxicity was assessed by measurement of the activity of mitochondrial dehydrogenases of viable cells (33) . Cells were seeded on 1ml microtitration plates at cell densities of 10 X 10 6 /1, 50 X 10 6 /1, and 100 X 10 6 /1. Twentyfour hours after plating cells were treated with the test compounds for 24 hours. 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) was added di^· rectly to the wells. After 3 hours at 37 °C media was removed, the formazan was solubilized in dimethylsulphoxide/acetic acid/SDS (100 g/1 SDS, 100 mmol/1 acetic acid in dimethylsulphoxide) and the plates were read on a Microplate Autoreader (Bio-Tek Instruments, Winooski, USA) at 570 nm. The formazan is produced proportional to the dehydrogenase activity.
Morphology
After treatment with the test compound cells were harvested and washed twice with ice-cold phosphate buffered saline and fixed in ice-cold glutaraldehyde (25 g/1) in 0.2 mol/1 phosphate buffer, pH 7.2. After 3 hours of fixation the cells were washed with phosphate buffered saline and postfixation with 1% osmium tetroxide was employed. The specimens were washed in distilled water, dehydrated in a series of graded ethanol solutions and routinely embedded in Epon 812. Ultrathin section were cut with an ultramicrotome (Reichert, Vienna, Austria) and examined in a Zeiss EM9S/2 electron microscope (Zeiss, Oberkochen, Germany).
Statistics
Statistical comparison between the control groups and the treated groups were made, using analysis of variance followed by Sludenfs t-test.
Results

Morphology
Electron microscopical comparisons of hepatoma cell lines (treated and untreated) were carried out to confirm proliferation by the application of clofibric acid. HepG2 cells presented inconspicuously. They were provided with abundant free ribosomes, contained short segments of rough endoplasmic reticulum, Golgi areas and cristaetype mitochondria ( fig. 1 ). Peroxisomes were rarely identified. These organelles were mostly oval in shape fig. 1 , inserts). After treatment with clofibric acid, the number of microperoxisomal profiles was increased but morphology and size of the individual organelles appeared unchanged ( fig. 2) .
Comparable results were obtained with the rat hepatoma cell line MH1C1 (results not shown).
Cytotoxicity
The toxicological effects of the compounds used were verified by measurement of the mitochondrial dehydrogenases of the cells in order to estimate the concentra- fig. 1 ). The number of microperoxisomes, however, is increased (encircled regions; two of them are shown at higher magnification in the inserts). Note that mitochondrial volume also appears slightly enlarged. Magnification: X 1900; insert X 8900. tion range of cytotoxicity, because toxicological effects need to be avoided for proliferation experiments. The results of the cytotoxicity assays indicate that clofibric acid and triiodothyronine do not influence the viability of both cell lines at concentrations below 5 mmol/1 and 100 μηιοΙ/1, respectively (data not shown). Cetaben treated cells already show a significant response at 10 μιηοΐ/ΐ. The fractional survivals of HepG2 and MH1C1 cell lines at a number of 100000 cells per well treated with 100 μιηοΐ/ΐ cetaben were 66% and 45% of control (p < 0.001) respectively ( fig. 3: Α-B) . The cytotoxic effect was more pronounced at a cell number of 10000, where the fractional survival for both cell lines was 37% (p < 0.001). The rat hepatoma cell line showed a greater sensitivity at higher cell number towards cetaben than the human cell line ( fig. 3: Α-B) . Since cytotoxicity was lower at higher cell densities confluent monolayers were used for all experiments. These findings agree with previous morphological studies on rat hepatocytes (34) .
Enzymes
In order to quantify the difference of the induction of peroxisomal proliferation between human (HepG2) and rat (MH1C1) cells, peroxisomal and mitochondrial enzymatic activities were determined.
In HepG2 3 mmol/1 clofibric acid had no effect on thiolase and the peroxisomal bifunctional enzyme activities. The activity of catalase was increased from 19.9 ±2.1 to 26.7 ± 2.7 mU/mg (p < 0.01), succinate dehydrogenase activity from 13.5 ± 0.7 to 18 ± 2.5 mU/mg by 3 mmol/1 clofibric acid (see tab. 1A). Catalase activity was increased by 10 μπιοΐ/ΐ and 100 μπιοΐ/ΐ cetaben to about 120% of control (p < 0.01; control activity: 17.7 ± 1.2 mU/mg), whereas the peroxisomal bifunctional enzyme was not affected (control activity: 37.9 ± 4.4 mU/mg). Ten μτηοΐ/ΐ cetaben did not alter the activity of succinate dehydrogenase, whereas the activity was decreased by 100 μιηοΐ/ΐ cetaben from 11.8 ± 1.0 to 8,7 ± 1.4 mU/mg (p < 0.01). Thiolase activity was slightly The values are given as % of control ± %SEM. *p<0.01; ** ρ < 0.02; η indicates the number of experiments. The specific activities are given in the result section.
enhanced by 10 μηαοΐ/ΐ cetaben from 319.5 ±43.6 to 379.3 ± 30.1 mU/mg, but 100 μΐΏθΙ/l cetaben slightly decreased the activity to 283.6 ± 35 πιο/mg (tab. 1A). In HepG2 cells the activities of all enzymes were not affected by treatment with 10 μπιοΐ/ΐ and 100 μηιοΐ/ΐ triiodothyronine (data not shown).
Three mmol/1 clofibric acid did not increase the activities of catalase (control activity 71.1 ±1.9 mU/mg), succinate dehydrogenase (control activity 7.1 ± 2.5 mil/ mg) and the peroxisomal bifunctional enzyme (control activity 52.9 ±5.4 mU/mg) in MH1C1 cells, whereas thiolase activity was enhanced from 166.5 ±21.9 to 207.6 ± 12.5 mU/mg (tab. IB). The mitochondria! marker succinate dehydrogenase was decreased by 10 μιυοί/ΐ cetaben from 8.9 ± 1.2 to 6.7 ± 0.7 mU/mg and further significantly decreased by 100 μιηοΐ/ΐ cetaben to 5.1 ± 0. sion of the corresponding genes, we determined the cellular mRNA levels after 24 hours of incubation of HepG2 and MH1C1 cells with 3 mmol/1 clofibric acid, 10 μιηοΐ/ΐ and 100 μηιοΐ/ΐ cetaben with different amounts of RNA. Cell monolayers from the corresponding subcultures, which were used for determination of enzyme activities or cytotoxicity assays, were incubated in parallel in Dtdbecco's Modified Eagles medium with or without peroxisomal proliferators. mRNA levels were assayed by slot-blotting, using specific 32 P-labelled probes ( fig. 6, 7 and 8) , as described in Materials and Methods. The -actin mRNA level was used as an internal standard. As shown in table 2 catalase mRNA was 2.6 fold higher in HepG2 cells treated with 3 mmol/1 clofibric acid than in controls (p < 0.001). The significant increase of mRNA levels induced by clofibric acid also correlates with the higher activity of catalase (tab. 1). Interestingly the mRNA levels of the peroxisomal bifiinctional en- which correlates well with the enzyme activities in HepG2 (tab. 1).
The mRNA level for the peroxisomal bifunctional enzyme in HepG2 cells treated with 10 μιηοΐ/ΐ cetaben was elevated significantly to 2.3 fold as compared with the control (p<0.01), whereas treatment with 100 μιηοΐ/ΐ cetaben did not cause a significant increase. These findings do not correlate with the enzymatic activities of the peroxisomal bifunctional enzyme which remained unchanged at all concentrations of cetaben.
The mRNA for fatty acyl-CoA oxidase of MH1C1 cells was increased 1.8 fold (p < 0.001) by 3 mmol/1 clofibric acid which correlates well with the findings of Thangada et al. (34) using Ciprofibrate in primary hepatocyte cultures. Cetaben treated cells showed a similar increase in fatty acyl-CoA oxidase (2.4 fold, p < 0.01) using 100 μιηοΐ/ΐ cetaben (tab. 2).
Catalase mRNA was not affected by 3 mmol/1 clofibric acid (tab. 2) which parallels the enzymatic activity.
Discussion
The main objective of the present study was to show the difference in the regulation of the peroxisomal β-oxidation of a human (HepG2) and rat (MH1C1) cell line. In order to elucidate if the effects on the peroxisomal -oxidation are correlated with the cytotoxicity of the chemicals a cytotoxicity assay was carried out. This assay indicates that clofibric acid and triiodothyronine at concentration of 5 mmol/1 and 100 μιηοΐ/ΐ, respectively, are not toxic, whereas cetaben is highly toxic even at low concentrations (100 μιηοΐ/ΐ). Therefore the effects of higher concentrations of cetaben on the peroxisomal -oxidation are superimposed by its cytotoxicity. Succinate dehydrogenase, a mitochondrial marker enzyme, was used to check the status of the mitochondrial energy producing system to verify the energy state of the cells. Clofibric acid enhances succinate dehydrogenase whereas cetaben, due to its cytotoxicity, significantly decreases its activity (see tab. 1). This differential effect is more pronounced in MH1C1 cells indicating that rat cells are more sensitive to peroxisomal proliferators. On the other hand the activity of catalase, a peroxisomal marker, is increased in HepG2 cells by cetaben and clofibric acid, which is caused by a much higher response of mRNA synthesis (see tab. 1 and 2), and additionally the response of mRNA by clofibric acid treated cells is much higher than the increase in activity. Moreover the activities of the peroxisomal bifunctional enzyme in both cell lines are unaffected, although the mRNA level was enhanced to 2.3 fold by 10 μιηοΐ/ΐ cetaben in HepG2 cells. In order to elucidate whether the increase of the activities of peroxisomal enzymes in hepatoma cell lines is weaker than in primary hepatocytes (34) or whether the increase is delayed, as suggested by the higher mRNA levels, long term studies have to be carried out.
It seems that the proliferation of the peroxisomal bifunctional enzyme is more pronounced if compared to other enzymes like succinate dehydrogenase (at 10 μπιοΐ/ΐ cetaben enzyme activity is 75% of control).
Interestingly the response of thiolase to clofibric acid and cetaben is higher in MH1C1 cells whereas the response in HepG2 varies. The decrease of the activity of thiolase at 100 μιηοΐ/ΐ cetaben seems to be due to the high cytotoxicity. Cetaben also increases the activity of the peroxisomal -oxidation system but this effect is compensated by the cytotoxicity of the compound.
At the concentrations used triiodothyronine does not trigger any response at all, which can be explained by the difference in the receptor mediated response (12) . The effect of hypolipidaemic drugs seen in our cell model is less pronounced than in rat liver but stronger in the rat cell line MH1C1 than in the human cell line HepG2, but is in accordance with previous findings of Graham et al. (20) in primates and of Hanefeld et al. (35) in humans which indicates that the peroxisomal proliferation in human and primate is not as pronounced as in rat, although the lipid lowering effect is present in human (5) . The hypotriglyceridaemic action of the se drugs is reported to be due to the decrease of apolipoprotein C-III gene expression, which was demonstrated by Staels et al. (36) in rat and human hepatocytes. Therefore this weak response of HepG2 to peroxisomal proliferators is in accordance with the assumed effect in human liver in vivo. Similar findings using human and rat hepatic cell lines have been previously reported by Scotto et al. (37) using clofibrate and Brocard et al. (38) using ciprofibrate.
Our results indicate that the human hepatoma cell line HepG2, as previously indicated by Watkins et al. (39) , is an appropriate model for studies of the influence of hypolipidaemic agents on the peroxisomal enzyme system.
